![]() | Up a level |
Nahvijou, A. and Safari, H. and Ameri, H. (2021) Correction to: Psychometric properties of the SF-6Dv2 in an Iranian breast cancer population (Breast Cancer, (2021), 28, 4, (937-943), 10.1007/s12282-021-01230-3). Breast Cancer, 28 (4). p. 944.
Nahvijou, A. and Safari, H. and Yousefi, M. and Rajabi, M. and Arab-Zozani, M. and Ameri, H. (2021) Mapping the cancer-specific FACT-B onto the generic SF-6Dv2. Breast Cancer, 28 (1). pp. 130-136.
Nahvijou, A. and Safari, H. and Ameri, H. (2021) Psychometric properties of the SF-6Dv2 in an Iranian breast cancer population. Breast Cancer, 28 (4). pp. 937-943.
Nahvijou, A. and Safari, H. and Ameri, H. (2020) Comparing the performance of the EQ-5D-5L with two versions of the SF-6Dv2 in patients with breast cancer. Health Services and Outcomes Research Methodology, 20 (2-3). pp. 183-194.
Arab-Zozani, M. and Hashemi, F. and Safari, H. and Yousefi, M. and Ameri, H. (2020) Health-related quality of life and its associated factors in COVID-19 patients. Osong Public Health and Research Perspectives, 11 (5). pp. 296-302.
Rezapour, A. and Tavakoli, N. and Akbar, S. and Hajahmadi, M. and Ameri, H. and Mohammadi, R. and Faradonbeh, S.B. (2020) Medical therapy versus percutaneous coronary intervention in ischemic heart disease: A cost-effectiveness analysis. Medical Journal of the Islamic Republic of Iran, 34. pp. 1-6.
Hassanipour, S. and Faradonbeh, S.B. and Momeni, K. and Heidarifard, Z. and Khosousi, M.-J. and Khosousi, L. and Ameri, H. and Arab-Zozani, M. (2020) A systematic review and meta-analysis of pregnancy and covid-19: Signs and symptoms, laboratory tests, and perinatal outcomes. International Journal of Reproductive BioMedicine, 18 (12). pp. 1005-1018.